Feasibility Of Real-Time Cell-Of-Origin Subtype Identification By Gene Expression Profile In The Phase 3 Trial Of Lenalidomide Plus R-Chop Vs Placebo Plus R-Chop In Patients With Untreated Abc-Type Diffuse Large B-Cell Lymphoma (Robust).
JOURNAL OF CLINICAL ONCOLOGY（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要